Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects

Konstantinos Drosopoulos1, Alexander Pintzas

  • 1Laboratory of Signal Mediated Gene Expression, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece.

Insights

Targeted cancer therapy is advancing, focusing on molecular networks and apoptosis pathways. This review explores targeted agents, their regulation by oncogenes, and future patient-tailored strategies for complex cancer treatment.

Area of Science:

  • Molecular Oncology
  • Cancer Therapeutics
  • Apoptosis Signaling

Background:

  • Advances in understanding cancer molecular networks enable targeted therapy development.
  • Targeted agents are crucial for personalized cancer treatment strategies.
  • Complexity in therapeutic approaches necessitates a comprehensive review.

Purpose of the Study:

  • To review functions, expression, and aberrations of targeted factors in cancer.
  • To focus on factors involved in death receptor-induced apoptosis.
  • To discuss regulation by oncogenes and future therapeutic strategies.

Main Methods:

  • Literature review of targeted agents and apoptosis-related factors.
  • Analysis of in vivo expression patterns and molecular aberrations.
  • Examination of oncogene regulation of targeted pathways.

Main Results:

  • Identified key factors in molecular networks driving cancer development.
  • Detailed functions and aberrations of current and potential therapeutic targets.
  • Highlighted regulation of apoptosis by classical oncogenes (RAS, MYC, HER2).

Conclusions:

  • Targeted therapy holds promise for patient-tailored cancer treatment.
  • Understanding apoptosis regulation is key to developing effective agents.
  • Orthologic systemic approaches are vital for future personalized therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...